nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP1A2—Pentoxifylline—systemic scleroderma	0.108	0.214	CbGbCtD
Modafinil—CYP1A2—Leflunomide—systemic scleroderma	0.103	0.204	CbGbCtD
Modafinil—CYP2C9—Leflunomide—systemic scleroderma	0.0932	0.184	CbGbCtD
Modafinil—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0859	0.17	CbGbCtD
Modafinil—CYP2C19—Prednisone—systemic scleroderma	0.0554	0.109	CbGbCtD
Modafinil—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0335	0.0661	CbGbCtD
Modafinil—CYP3A4—Prednisone—systemic scleroderma	0.0268	0.0528	CbGbCtD
Modafinil—Weight increased—Prednisone—systemic scleroderma	0.000316	0.000641	CcSEcCtD
Modafinil—Ataxia—Methotrexate—systemic scleroderma	0.000316	0.000641	CcSEcCtD
Modafinil—Constipation—Mycophenolic acid—systemic scleroderma	0.000316	0.00064	CcSEcCtD
Modafinil—Pain—Mycophenolic acid—systemic scleroderma	0.000316	0.00064	CcSEcCtD
Modafinil—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00064	CcSEcCtD
Modafinil—Weight decreased—Prednisone—systemic scleroderma	0.000314	0.000637	CcSEcCtD
Modafinil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000636	CcSEcCtD
Modafinil—Hyperglycaemia—Prednisone—systemic scleroderma	0.000314	0.000635	CcSEcCtD
Modafinil—Cough—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000632	CcSEcCtD
Modafinil—Hypotension—Lisinopril—systemic scleroderma	0.000311	0.00063	CcSEcCtD
Modafinil—Dizziness—Captopril—systemic scleroderma	0.000311	0.00063	CcSEcCtD
Modafinil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00031	0.000627	CcSEcCtD
Modafinil—Depression—Prednisone—systemic scleroderma	0.000309	0.000626	CcSEcCtD
Modafinil—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000308	0.000625	CcSEcCtD
Modafinil—Urticaria—Leflunomide—systemic scleroderma	0.000308	0.000624	CcSEcCtD
Modafinil—Body temperature increased—Leflunomide—systemic scleroderma	0.000306	0.000621	CcSEcCtD
Modafinil—Abdominal pain—Leflunomide—systemic scleroderma	0.000306	0.000621	CcSEcCtD
Modafinil—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000304	0.000617	CcSEcCtD
Modafinil—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000617	CcSEcCtD
Modafinil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000617	CcSEcCtD
Modafinil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000617	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000303	0.000615	CcSEcCtD
Modafinil—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000614	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000303	0.000613	CcSEcCtD
Modafinil—Hypersensitivity—Azathioprine—systemic scleroderma	0.000302	0.000612	CcSEcCtD
Modafinil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000302	0.000612	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000612	CcSEcCtD
Modafinil—Insomnia—Lisinopril—systemic scleroderma	0.000301	0.00061	CcSEcCtD
Modafinil—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000609	CcSEcCtD
Modafinil—Paraesthesia—Lisinopril—systemic scleroderma	0.000299	0.000606	CcSEcCtD
Modafinil—Vomiting—Captopril—systemic scleroderma	0.000299	0.000606	CcSEcCtD
Modafinil—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000603	CcSEcCtD
Modafinil—Dyspnoea—Lisinopril—systemic scleroderma	0.000297	0.000601	CcSEcCtD
Modafinil—Rash—Captopril—systemic scleroderma	0.000296	0.000601	CcSEcCtD
Modafinil—Dermatitis—Captopril—systemic scleroderma	0.000296	0.0006	CcSEcCtD
Modafinil—Somnolence—Lisinopril—systemic scleroderma	0.000296	0.0006	CcSEcCtD
Modafinil—Headache—Captopril—systemic scleroderma	0.000294	0.000597	CcSEcCtD
Modafinil—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000294	0.000596	CcSEcCtD
Modafinil—Dyspepsia—Lisinopril—systemic scleroderma	0.000293	0.000594	CcSEcCtD
Modafinil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000292	0.000592	CcSEcCtD
Modafinil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000292	0.000592	CcSEcCtD
Modafinil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000591	CcSEcCtD
Modafinil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000591	CcSEcCtD
Modafinil—Asthma—Methotrexate—systemic scleroderma	0.00029	0.000589	CcSEcCtD
Modafinil—Infection—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000587	CcSEcCtD
Modafinil—Decreased appetite—Lisinopril—systemic scleroderma	0.000289	0.000586	CcSEcCtD
Modafinil—Eosinophilia—Methotrexate—systemic scleroderma	0.000288	0.000583	CcSEcCtD
Modafinil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000287	0.000582	CcSEcCtD
Modafinil—Fatigue—Lisinopril—systemic scleroderma	0.000287	0.000582	CcSEcCtD
Modafinil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000581	CcSEcCtD
Modafinil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000286	0.00058	CcSEcCtD
Modafinil—Hypersensitivity—Leflunomide—systemic scleroderma	0.000285	0.000578	CcSEcCtD
Modafinil—Constipation—Lisinopril—systemic scleroderma	0.000285	0.000577	CcSEcCtD
Modafinil—Pain—Lisinopril—systemic scleroderma	0.000285	0.000577	CcSEcCtD
Modafinil—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000577	CcSEcCtD
Modafinil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000574	CcSEcCtD
Modafinil—Bradycardia—Prednisone—systemic scleroderma	0.000283	0.000574	CcSEcCtD
Modafinil—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000571	CcSEcCtD
Modafinil—Diarrhoea—Azathioprine—systemic scleroderma	0.000281	0.000569	CcSEcCtD
Modafinil—Nausea—Captopril—systemic scleroderma	0.000279	0.000566	CcSEcCtD
Modafinil—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000563	CcSEcCtD
Modafinil—Asthenia—Leflunomide—systemic scleroderma	0.000278	0.000563	CcSEcCtD
Modafinil—Hallucination—Prednisone—systemic scleroderma	0.000277	0.000561	CcSEcCtD
Modafinil—Pancytopenia—Methotrexate—systemic scleroderma	0.000276	0.000559	CcSEcCtD
Modafinil—Feeling abnormal—Lisinopril—systemic scleroderma	0.000274	0.000556	CcSEcCtD
Modafinil—Pruritus—Leflunomide—systemic scleroderma	0.000274	0.000555	CcSEcCtD
Modafinil—Connective tissue disorder—Prednisone—systemic scleroderma	0.000273	0.000554	CcSEcCtD
Modafinil—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000552	CcSEcCtD
Modafinil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000272	0.000552	CcSEcCtD
Modafinil—Dizziness—Azathioprine—systemic scleroderma	0.000271	0.00055	CcSEcCtD
Modafinil—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000268	0.000542	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000538	CcSEcCtD
Modafinil—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000265	0.000537	CcSEcCtD
Modafinil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000265	0.000537	CcSEcCtD
Modafinil—Diarrhoea—Leflunomide—systemic scleroderma	0.000265	0.000537	CcSEcCtD
Modafinil—Urticaria—Lisinopril—systemic scleroderma	0.000264	0.000536	CcSEcCtD
Modafinil—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000535	CcSEcCtD
Modafinil—Abdominal pain—Lisinopril—systemic scleroderma	0.000263	0.000533	CcSEcCtD
Modafinil—Body temperature increased—Lisinopril—systemic scleroderma	0.000263	0.000533	CcSEcCtD
Modafinil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000531	CcSEcCtD
Modafinil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000261	0.00053	CcSEcCtD
Modafinil—Vomiting—Azathioprine—systemic scleroderma	0.000261	0.000529	CcSEcCtD
Modafinil—Pneumonia—Methotrexate—systemic scleroderma	0.000261	0.000528	CcSEcCtD
Modafinil—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000527	CcSEcCtD
Modafinil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000525	CcSEcCtD
Modafinil—Drowsiness—Methotrexate—systemic scleroderma	0.000259	0.000525	CcSEcCtD
Modafinil—Rash—Azathioprine—systemic scleroderma	0.000259	0.000524	CcSEcCtD
Modafinil—Dermatitis—Azathioprine—systemic scleroderma	0.000258	0.000524	CcSEcCtD
Modafinil—Depression—Methotrexate—systemic scleroderma	0.000258	0.000523	CcSEcCtD
Modafinil—Headache—Azathioprine—systemic scleroderma	0.000257	0.000521	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000257	0.00052	CcSEcCtD
Modafinil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.00052	CcSEcCtD
Modafinil—Dizziness—Leflunomide—systemic scleroderma	0.000256	0.000519	CcSEcCtD
Modafinil—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000514	CcSEcCtD
Modafinil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000253	0.000512	CcSEcCtD
Modafinil—Stomatitis—Methotrexate—systemic scleroderma	0.000252	0.000512	CcSEcCtD
Modafinil—Angiopathy—Prednisone—systemic scleroderma	0.000252	0.000512	CcSEcCtD
Modafinil—Conjunctivitis—Methotrexate—systemic scleroderma	0.000252	0.00051	CcSEcCtD
Modafinil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00051	CcSEcCtD
Modafinil—Immune system disorder—Prednisone—systemic scleroderma	0.000251	0.000509	CcSEcCtD
Modafinil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000505	CcSEcCtD
Modafinil—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000505	CcSEcCtD
Modafinil—Arrhythmia—Prednisone—systemic scleroderma	0.000249	0.000504	CcSEcCtD
Modafinil—Sweating—Methotrexate—systemic scleroderma	0.000248	0.000503	CcSEcCtD
Modafinil—Haematuria—Methotrexate—systemic scleroderma	0.000247	0.000501	CcSEcCtD
Modafinil—Vomiting—Leflunomide—systemic scleroderma	0.000246	0.000499	CcSEcCtD
Modafinil—Hypersensitivity—Lisinopril—systemic scleroderma	0.000245	0.000497	CcSEcCtD
Modafinil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000244	0.000495	CcSEcCtD
Modafinil—Epistaxis—Methotrexate—systemic scleroderma	0.000244	0.000495	CcSEcCtD
Modafinil—Rash—Leflunomide—systemic scleroderma	0.000244	0.000495	CcSEcCtD
Modafinil—Dermatitis—Leflunomide—systemic scleroderma	0.000244	0.000495	CcSEcCtD
Modafinil—Mental disorder—Prednisone—systemic scleroderma	0.000244	0.000494	CcSEcCtD
Modafinil—Nausea—Azathioprine—systemic scleroderma	0.000244	0.000494	CcSEcCtD
Modafinil—Headache—Leflunomide—systemic scleroderma	0.000243	0.000492	CcSEcCtD
Modafinil—Malnutrition—Prednisone—systemic scleroderma	0.000242	0.000491	CcSEcCtD
Modafinil—Agranulocytosis—Methotrexate—systemic scleroderma	0.000242	0.00049	CcSEcCtD
Modafinil—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000487	CcSEcCtD
Modafinil—Asthenia—Lisinopril—systemic scleroderma	0.000239	0.000484	CcSEcCtD
Modafinil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000483	CcSEcCtD
Modafinil—Pruritus—Lisinopril—systemic scleroderma	0.000235	0.000477	CcSEcCtD
Modafinil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000235	0.000476	CcSEcCtD
Modafinil—Rash—Mycophenolic acid—systemic scleroderma	0.000233	0.000472	CcSEcCtD
Modafinil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000233	0.000472	CcSEcCtD
Modafinil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000232	0.00047	CcSEcCtD
Modafinil—Headache—Mycophenolic acid—systemic scleroderma	0.000231	0.000469	CcSEcCtD
Modafinil—Pharyngitis—Methotrexate—systemic scleroderma	0.000231	0.000468	CcSEcCtD
Modafinil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000467	CcSEcCtD
Modafinil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000467	CcSEcCtD
Modafinil—Nausea—Leflunomide—systemic scleroderma	0.00023	0.000466	CcSEcCtD
Modafinil—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00023	0.000465	CcSEcCtD
Modafinil—Urethral disorder—Methotrexate—systemic scleroderma	0.000228	0.000462	CcSEcCtD
Modafinil—Diarrhoea—Lisinopril—systemic scleroderma	0.000228	0.000462	CcSEcCtD
Modafinil—Ill-defined disorder—Prednisone—systemic scleroderma	0.000225	0.000455	CcSEcCtD
Modafinil—Visual impairment—Methotrexate—systemic scleroderma	0.000224	0.000454	CcSEcCtD
Modafinil—Anaemia—Prednisone—systemic scleroderma	0.000224	0.000454	CcSEcCtD
Modafinil—Agitation—Prednisone—systemic scleroderma	0.000223	0.000451	CcSEcCtD
Modafinil—Angioedema—Prednisone—systemic scleroderma	0.000221	0.000449	CcSEcCtD
Modafinil—Dizziness—Lisinopril—systemic scleroderma	0.00022	0.000446	CcSEcCtD
Modafinil—Erythema multiforme—Methotrexate—systemic scleroderma	0.00022	0.000446	CcSEcCtD
Modafinil—Nausea—Mycophenolic acid—systemic scleroderma	0.000219	0.000445	CcSEcCtD
Modafinil—Malaise—Prednisone—systemic scleroderma	0.000218	0.000443	CcSEcCtD
Modafinil—Vertigo—Prednisone—systemic scleroderma	0.000218	0.000441	CcSEcCtD
Modafinil—Syncope—Prednisone—systemic scleroderma	0.000217	0.00044	CcSEcCtD
Modafinil—Cardiac disorder—Methotrexate—systemic scleroderma	0.000216	0.000437	CcSEcCtD
Modafinil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000435	CcSEcCtD
Modafinil—Loss of consciousness—Prednisone—systemic scleroderma	0.000213	0.000431	CcSEcCtD
Modafinil—Vomiting—Lisinopril—systemic scleroderma	0.000212	0.000429	CcSEcCtD
Modafinil—Angiopathy—Methotrexate—systemic scleroderma	0.000211	0.000428	CcSEcCtD
Modafinil—Immune system disorder—Methotrexate—systemic scleroderma	0.00021	0.000426	CcSEcCtD
Modafinil—Rash—Lisinopril—systemic scleroderma	0.00021	0.000425	CcSEcCtD
Modafinil—Convulsion—Prednisone—systemic scleroderma	0.00021	0.000425	CcSEcCtD
Modafinil—Dermatitis—Lisinopril—systemic scleroderma	0.00021	0.000425	CcSEcCtD
Modafinil—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00021	0.000425	CcSEcCtD
Modafinil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000424	CcSEcCtD
Modafinil—Hypertension—Prednisone—systemic scleroderma	0.000209	0.000424	CcSEcCtD
Modafinil—Chills—Methotrexate—systemic scleroderma	0.000209	0.000423	CcSEcCtD
Modafinil—Headache—Lisinopril—systemic scleroderma	0.000208	0.000423	CcSEcCtD
Modafinil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000418	CcSEcCtD
Modafinil—Myalgia—Prednisone—systemic scleroderma	0.000206	0.000418	CcSEcCtD
Modafinil—Arthralgia—Prednisone—systemic scleroderma	0.000206	0.000418	CcSEcCtD
Modafinil—Anxiety—Prednisone—systemic scleroderma	0.000205	0.000416	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000205	0.000415	CcSEcCtD
Modafinil—Discomfort—Prednisone—systemic scleroderma	0.000204	0.000413	CcSEcCtD
Modafinil—Mental disorder—Methotrexate—systemic scleroderma	0.000204	0.000413	CcSEcCtD
Modafinil—Malnutrition—Methotrexate—systemic scleroderma	0.000202	0.00041	CcSEcCtD
Modafinil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000404	CcSEcCtD
Modafinil—Dysgeusia—Methotrexate—systemic scleroderma	0.000198	0.000402	CcSEcCtD
Modafinil—Nausea—Lisinopril—systemic scleroderma	0.000198	0.000401	CcSEcCtD
Modafinil—Anaphylactic shock—Prednisone—systemic scleroderma	0.000198	0.000401	CcSEcCtD
Modafinil—Oedema—Prednisone—systemic scleroderma	0.000198	0.000401	CcSEcCtD
Modafinil—Infection—Prednisone—systemic scleroderma	0.000196	0.000398	CcSEcCtD
Modafinil—Back pain—Methotrexate—systemic scleroderma	0.000196	0.000397	CcSEcCtD
Modafinil—Shock—Prednisone—systemic scleroderma	0.000194	0.000394	CcSEcCtD
Modafinil—Nervous system disorder—Prednisone—systemic scleroderma	0.000194	0.000393	CcSEcCtD
Modafinil—Tachycardia—Prednisone—systemic scleroderma	0.000193	0.000391	CcSEcCtD
Modafinil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000391	CcSEcCtD
Modafinil—Skin disorder—Prednisone—systemic scleroderma	0.000192	0.000389	CcSEcCtD
Modafinil—Hyperhidrosis—Prednisone—systemic scleroderma	0.000191	0.000387	CcSEcCtD
Modafinil—Anorexia—Prednisone—systemic scleroderma	0.000188	0.000382	CcSEcCtD
Modafinil—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000188	0.000381	CcSEcCtD
Modafinil—Anaemia—Methotrexate—systemic scleroderma	0.000187	0.000379	CcSEcCtD
Modafinil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000376	CcSEcCtD
Modafinil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000373	CcSEcCtD
Modafinil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000372	CcSEcCtD
Modafinil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00037	CcSEcCtD
Modafinil—Malaise—Methotrexate—systemic scleroderma	0.000183	0.00037	CcSEcCtD
Modafinil—Vertigo—Methotrexate—systemic scleroderma	0.000182	0.000369	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00018	0.000365	CcSEcCtD
Modafinil—Insomnia—Prednisone—systemic scleroderma	0.000179	0.000362	CcSEcCtD
Modafinil—Paraesthesia—Prednisone—systemic scleroderma	0.000177	0.00036	CcSEcCtD
Modafinil—Cough—Methotrexate—systemic scleroderma	0.000177	0.000358	CcSEcCtD
Modafinil—Convulsion—Methotrexate—systemic scleroderma	0.000175	0.000355	CcSEcCtD
Modafinil—Dyspepsia—Prednisone—systemic scleroderma	0.000174	0.000353	CcSEcCtD
Modafinil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000351	CcSEcCtD
Modafinil—Myalgia—Methotrexate—systemic scleroderma	0.000172	0.000349	CcSEcCtD
Modafinil—Arthralgia—Methotrexate—systemic scleroderma	0.000172	0.000349	CcSEcCtD
Modafinil—Chest pain—Methotrexate—systemic scleroderma	0.000172	0.000349	CcSEcCtD
Modafinil—Decreased appetite—Prednisone—systemic scleroderma	0.000172	0.000348	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000171	0.000347	CcSEcCtD
Modafinil—Fatigue—Prednisone—systemic scleroderma	0.00017	0.000345	CcSEcCtD
Modafinil—Discomfort—Methotrexate—systemic scleroderma	0.00017	0.000345	CcSEcCtD
Modafinil—Constipation—Prednisone—systemic scleroderma	0.000169	0.000343	CcSEcCtD
Modafinil—Confusional state—Methotrexate—systemic scleroderma	0.000167	0.000338	CcSEcCtD
Modafinil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000165	0.000335	CcSEcCtD
Modafinil—Infection—Methotrexate—systemic scleroderma	0.000164	0.000333	CcSEcCtD
Modafinil—Feeling abnormal—Prednisone—systemic scleroderma	0.000163	0.00033	CcSEcCtD
Modafinil—Nervous system disorder—Methotrexate—systemic scleroderma	0.000162	0.000328	CcSEcCtD
Modafinil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000162	0.000328	CcSEcCtD
Modafinil—Skin disorder—Methotrexate—systemic scleroderma	0.00016	0.000325	CcSEcCtD
Modafinil—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00016	0.000324	CcSEcCtD
Modafinil—Anorexia—Methotrexate—systemic scleroderma	0.000157	0.000319	CcSEcCtD
Modafinil—Urticaria—Prednisone—systemic scleroderma	0.000157	0.000318	CcSEcCtD
Modafinil—Body temperature increased—Prednisone—systemic scleroderma	0.000156	0.000317	CcSEcCtD
Modafinil—Abdominal pain—Prednisone—systemic scleroderma	0.000156	0.000317	CcSEcCtD
Modafinil—Hypotension—Methotrexate—systemic scleroderma	0.000154	0.000313	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00015	0.000305	CcSEcCtD
Modafinil—Insomnia—Methotrexate—systemic scleroderma	0.000149	0.000303	CcSEcCtD
Modafinil—Paraesthesia—Methotrexate—systemic scleroderma	0.000148	0.000301	CcSEcCtD
Modafinil—Dyspnoea—Methotrexate—systemic scleroderma	0.000147	0.000298	CcSEcCtD
Modafinil—Somnolence—Methotrexate—systemic scleroderma	0.000147	0.000298	CcSEcCtD
Modafinil—Hypersensitivity—Prednisone—systemic scleroderma	0.000146	0.000295	CcSEcCtD
Modafinil—Dyspepsia—Methotrexate—systemic scleroderma	0.000145	0.000295	CcSEcCtD
Modafinil—Decreased appetite—Methotrexate—systemic scleroderma	0.000144	0.000291	CcSEcCtD
Modafinil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000143	0.000289	CcSEcCtD
Modafinil—Fatigue—Methotrexate—systemic scleroderma	0.000142	0.000289	CcSEcCtD
Modafinil—Asthenia—Prednisone—systemic scleroderma	0.000142	0.000287	CcSEcCtD
Modafinil—Pain—Methotrexate—systemic scleroderma	0.000141	0.000286	CcSEcCtD
Modafinil—Pruritus—Prednisone—systemic scleroderma	0.00014	0.000283	CcSEcCtD
Modafinil—Feeling abnormal—Methotrexate—systemic scleroderma	0.000136	0.000276	CcSEcCtD
Modafinil—Diarrhoea—Prednisone—systemic scleroderma	0.000135	0.000274	CcSEcCtD
Modafinil—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000135	0.000274	CcSEcCtD
Modafinil—Urticaria—Methotrexate—systemic scleroderma	0.000131	0.000266	CcSEcCtD
Modafinil—Dizziness—Prednisone—systemic scleroderma	0.000131	0.000265	CcSEcCtD
Modafinil—Abdominal pain—Methotrexate—systemic scleroderma	0.000131	0.000265	CcSEcCtD
Modafinil—Body temperature increased—Methotrexate—systemic scleroderma	0.000131	0.000265	CcSEcCtD
Modafinil—Vomiting—Prednisone—systemic scleroderma	0.000126	0.000255	CcSEcCtD
Modafinil—Rash—Prednisone—systemic scleroderma	0.000125	0.000253	CcSEcCtD
Modafinil—Dermatitis—Prednisone—systemic scleroderma	0.000125	0.000252	CcSEcCtD
Modafinil—Headache—Prednisone—systemic scleroderma	0.000124	0.000251	CcSEcCtD
Modafinil—Hypersensitivity—Methotrexate—systemic scleroderma	0.000122	0.000247	CcSEcCtD
Modafinil—Asthenia—Methotrexate—systemic scleroderma	0.000119	0.00024	CcSEcCtD
Modafinil—Nausea—Prednisone—systemic scleroderma	0.000117	0.000238	CcSEcCtD
Modafinil—Pruritus—Methotrexate—systemic scleroderma	0.000117	0.000237	CcSEcCtD
Modafinil—Diarrhoea—Methotrexate—systemic scleroderma	0.000113	0.000229	CcSEcCtD
Modafinil—Dizziness—Methotrexate—systemic scleroderma	0.000109	0.000221	CcSEcCtD
Modafinil—Vomiting—Methotrexate—systemic scleroderma	0.000105	0.000213	CcSEcCtD
Modafinil—Rash—Methotrexate—systemic scleroderma	0.000104	0.000211	CcSEcCtD
Modafinil—Dermatitis—Methotrexate—systemic scleroderma	0.000104	0.000211	CcSEcCtD
Modafinil—Headache—Methotrexate—systemic scleroderma	0.000103	0.00021	CcSEcCtD
Modafinil—Nausea—Methotrexate—systemic scleroderma	9.81e-05	0.000199	CcSEcCtD
